SCHEMBL15580678

SCHEMBL15580678

CCNc1nc(C)c2cc(-c3ccc(F)cc3F)c(=O)n(C)c2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.48
▸ HSD17B10 Q99714 5/20 0.48
▸ GLA P06280 4/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.48
▸ MEN1 O00255 4/20 0.45
▸ USP2 O75604 4/20 0.45
▸ CYP1A2 P05177 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ CASP1 P29466 3/20 0.45
▸ CASP7 P55210 3/20 0.45
▸ TSHR P16473 2/20 0.45
▸ HIF1A Q16665 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ PIK3CA P42336 10/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188692 0.89 ALDH1A1 (0.60) ALDH1A1HSD17B10GLAMAPK1KDM4E
SCHEMBL15580682 0.82 PIK3CA (0.50) ALDH1A1HSD17B10GLAMAPK1KDM4E
SCHEMBL2632910 0.79 PIK3CA (0.50) ALDH1A1HSD17B10GLAMAPK1KDM4E
SCHEMBL188697 0.77 ALDH1A1 (0.61) ALDH1A1HSD17B10GLAMAPK1KDM4E
SCHEMBL189369 0.76 ALDH1A1 (0.63) ALDH1A1HSD17B10GLAMAPK1KDM4E
SCHEMBL188829 0.74 ALDH1A1 (0.58) ALDH1A1HSD17B10GLAMAPK1KDM4E
SCHEMBL188991 0.73 KDM4E (0.59) ALDH1A1HSD17B10GLAMAPK1KDM4E
SCHEMBL24288255 0.72 USP2 (0.42) ALDH1A1HSD17B10GLAMAPK1HPGD
SCHEMBL6128333 0.72 PIK3CA (0.60) PIK3CA
SCHEMBL190097 0.72 KDM4E (0.60) ALDH1A1HSD17B10GLAMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139484-B9 METHODS OF TREATING CANCER USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K ALPHA EXELIXIS INC (US) 2014-06-11 — — EP disclosed
Send feedback